2025-09-28 - Analysis Report
Okay, here's an analysis of Intuitive Surgical (ISRG) based on the data you provided, formatted as requested with English reporting, numbers first, followed by analysis.

**Report on Intuitive Surgical Inc. (ISRG)**

Intuitive Surgical Inc. designs, manufactures, and markets the da Vinci surgical system and related instruments and accessories.

**1. Performance vs. S&P 500 (VOO)**

*   **ISRG Cumulative Return:** 69.09%
*   **VOO Cumulative Return:** 66.41%
*   **Absolute Spread (ISRG - VOO):**  2.68%
*   **Spread Range (Max: 67.6, Min: -41.6, Current: -38.0)**
*   **Relative Spread:** 3.3

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha | Beta | Cap(B) |
|------------|--------|--------|-------|------|--------|
| 2015-2017  | 65.0%  | 65.3%  | 55.0% | -0.0 | 43.6   |
| 2016-2018  | 61.0%  | 70.3%  | 62.0% | 0.0  | 57.2   |
| 2017-2019  | 50.0%  | 70.3%  | 46.0% | 0.0  | 70.6   |
| 2018-2020  | -6.0%  | 80.6%  | -32.0% | 0.1  | 97.8   |
| 2019-2021  | 36.0%  | 80.6%  | 7.0%  | 0.3  | 128.8  |
| 2020-2022  | 0.0%   | 80.6%  | -14.0% | 0.5  | 95.1   |
| 2021-2023  | 10.0%  | 77.6%  | -8.0%  | 1.0  | 120.9  |
| 2022-2024  | 26.0%  | 77.6%  | 14.0% | 1.0  | 187.1  |
| 2023-2025  | 15.0%  | 72.8%  | -20.0% | 0.5  | 158.1  |

**Analysis:**

*   **Outperformance:** ISRG has slightly outperformed the S&P 500 in cumulative return over the period examined.
*   **Relative Spread Position:** A relative spread of 3.3 suggests that the current spread between ISRG and VOO is near the lower end of its historical range.
*   **Alpha and Beta:** The alpha and beta values vary significantly across different time periods. The negative alpha values in recent years suggest underperformance relative to the market, while beta values close to 1 or higher indicate a higher correlation with the market's volatility. High MDD(Maximum Drawdown) means High Volatility.

**2. Recent Price Action**

*   **Current Price:** 441.12
*   **Previous Close:** 438.12
*   **Change:** 0.68
*   **5-Day Moving Average:** 443.62
*   **20-Day Moving Average:** 448.64
*   **60-Day Moving Average:** 478.82

**Analysis:**

*   **Price Action:** The stock price increased slightly in the last trading session.
*   **Moving Averages:** The current price is below all three moving averages (5, 20, and 60-day), indicating a potential short-term downtrend.

**3. Market Risk Indicators**

*   **MRI (Market Risk Indicator):** 0.9 (Medium Investment)
*   **RSI (Relative Strength Index):** 32.17 (Approaching Oversold)
*   **PPO (Percentage Price Oscillator):** 0.1797
*   **Hybrid Signal:**  cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.70) (Cash Ratio: 0% on 2025-09-11)
*   **Recent (20-Day) Relative Spread Change:** 2.9 (+), indicating short-term upward movement.
*   **Expected Return:** 91.4% (projected excess return vs. S&P 500 over 2+ years)

**Analysis:**

*   **MRI:** Suggests a medium level of investment risk based on the overall market conditions.
*   **RSI:** An RSI of 32.17 indicates that the stock is approaching oversold territory, which could signal a potential buying opportunity.
*   **PPO:** The PPO value suggests the presence of price oscillation.
*   **Hybrid Signal:** The hybrid signal recommends buying 80% of available cash, but notes a caution.
*   **Relative Spread Change:** The recent increase in relative spread suggests positive short-term momentum for ISRG compared to VOO.
*   **Expected Return:** A high expected return of 91.4% suggests that the stock is expected to significantly outperform the S&P 500 over the long term.
*   **Price Change:** The positive change of 0.68 from the previous close may reflect some short-term positive reaction.

**4. Recent News & Significant Events (Yahoo Finance)**

*   **Bullish Articles:** Several articles highlight the potential of Intuitive Surgical, with some suggesting it as a good investment (Motley Fool, Zacks).
*   **Market Outperformance:** One article notes ISRG outperforming the stock market (Zacks).
*   **Platform Expansion:** News about ISRG's SP platform expansion in Korea and Europe indicates growth opportunities (Zacks).
*   **Competitive Landscape:** An article discusses SS Innovations and the expansion of robotic surgery, highlighting the competitive environment.

**4-2. Analyst Opinions**

*   **Consensus:** Buy
*   **Mean Rating:** 1.94 (Buy)
*   **Number of Opinions:** 27
*   **Target Price:** Avg: 582.10, High: 685.00, Low: 350.00
*   **Recent Rating Changes:** No changes reported in the provided data.

**Analysis:**

*   **Analyst Sentiment:** The analyst consensus is positive, with a "Buy" rating and a mean rating indicating a favorable outlook.
*   **Price Target:** The average target price suggests potential upside from the current price level.  However, the wide range between the high and low target prices indicates some uncertainty among analysts.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출    |
|------------|------|---------|
| 2025-07-23 | 1.84 | 2.44 B$ |
| 2025-04-23 | 1.95 | 2.25 B$ |
| 2024-10-18 | 1.59 | 2.04 B$ |
| 2024-07-19 | 1.48 | 2.01 B$ |
| 2025-07-23 | 1.48 | 2.01 B$ |

**Analysis:**

*   **Revenue and EPS Trend:** The company shows a general trend of increasing revenue and EPS over the recent quarters.
*   **Inconsistency:** There's a duplicated entry for 2025-07-23 which skews the data, but overall the trend looks positive.

**6. Financial Information**

**Revenue and Profitability**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-06-30 | $2.44B    | 66.31%        |
| 2025-03-31 | $2.25B    | 64.69%        |
| 2024-12-31 | $2.41B    | 68.04%        |
| 2024-09-30 | $2.04B    | 67.41%        |
| 2024-06-30 | $2.01B    | 68.30%        |

**Capital and Profitability**

| Quarter    | Equity    | ROE   |
|------------|-----------|-------|
| 2025-06-30 | $17.85B   | 3.69% |
| 2025-03-31 | $17.11B   | 4.08% |
| 2024-12-31 | $16.43B   | 4.17% |
| 2024-09-30 | $15.58B   | 3.63% |
| 2024-06-30 | $14.71B   | 3.58% |

**Analysis:**

*   **Revenue Growth:**  Revenues show a generally increasing trend over the past year.
*   **Profit Margins:** Profit margins are consistently high, indicating strong profitability.
*   **Equity Growth:** Equity is steadily increasing, reflecting the company's ability to generate and retain earnings.
*   **ROE:**  ROE is relatively stable, suggesting consistent returns on equity.

**7. Overall Summary**

Based on the provided data, here's a summary of ISRG's situation:

*   **Performance:** ISRG has slightly outperformed the S&P 500, but recent performance has been weaker.
*   **Technicals:**  The stock is currently trading below its key moving averages, suggesting a potential short-term downtrend. However, the RSI is approaching oversold levels, which could present a buying opportunity.
*   **Market Sentiment:** Analyst sentiment is generally positive, with a "Buy" consensus and a significant upside potential based on target prices. Recent news articles also paint a generally positive picture.
*   **Fundamentals:** ISRG exhibits strong fundamentals, with growing revenues, high profit margins, and increasing equity.
*   **Risk:**  The Market Risk Indicator suggests a medium level of investment risk. However, historical data shows periods of high volatility (MDD).
*   **Expected Return:** The high expected return suggests significant long-term growth potential.

**Conclusion:**

ISRG appears to be a fundamentally sound company with positive long-term prospects. However, short-term technical indicators suggest caution. Investors should consider their risk tolerance and investment horizon before making a decision. The analyst consensus and positive news articles support a bullish outlook, but potential downsides include the competitive landscape and periods of high volatility. The current hybrid signal recommends a cautious buy.
